{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T13:57:58Z","timestamp":1770559078280,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701751"],"award-info":[{"award-number":["81701751"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871383"],"award-info":[{"award-number":["81871383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["21619104"],"award-info":[{"award-number":["21619104"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005930","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","award":["2020A1515011192"],"award-info":[{"award-number":["2020A1515011192"]}],"id":[{"id":"10.13039\/100005930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012692","name":"K. C. Wong Education Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012692","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004885","name":"Ume\u00e5 University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004024","name":"Jinan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008126","name":"JNUH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008126","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bmcl.2020.127513","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T22:05:21Z","timestamp":1598479521000},"page":"127513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Synthesis and preliminary evaluation of a novel positron emission tomography (PET) ligand for imaging fatty acid amide hydrolase (FAAH)"],"prefix":"10.1016","volume":"30","author":[{"given":"Zhen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiefeng","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qijun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guocong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-6315","authenticated-orcid":false,"given":"Steven H.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127513_b0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmcl.2020.127513_b0010","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/cr0782067","article-title":"Enzymatic pathways that regulate endocannabinoid signaling in the nervous system","volume":"108","author":"Ahn","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2020.127513_b0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrd2553","article-title":"Targeting the endocannabinoid system: to enhance or reduce?","volume":"7","author":"Di Marzo","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2020.127513_b0020","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2020.127513_b0025","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bmcl.2020.127513_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2020.127513_b0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2020.127513_b0040","doi-asserted-by":"crossref","unstructured":"Ueda N, Tsuboi K, Uyama T. Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways. FEBS J. 2013;280: 1874-1894.","DOI":"10.1111\/febs.12152"},{"key":"10.1016\/j.bmcl.2020.127513_b0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2020.127513_b0050","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2020.127513_b0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","article-title":"Structure and function of fatty acid amide hydrolase","volume":"74","author":"McKinney","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bmcl.2020.127513_b0060","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmcl.2020.127513_b0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2007.04.012","article-title":"Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes","volume":"27","author":"Battista","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bmcl.2020.127513_b0070","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2020.127513_b0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0074-7742(09)85005-8","article-title":"The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs","volume":"85","author":"Gaetani","year":"2009","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.bmcl.2020.127513_b0080","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2020.127513_b0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pain.2004.01.022","article-title":"Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia","volume":"109","author":"Lichtman","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.bmcl.2020.127513_b0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2020.127513_b0095","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bmcl.2020.127513_b0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.111.180257","article-title":"Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain","volume":"338","author":"Ahn","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2020.127513_b0105","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.bmcl.2020.127513_b0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/ml100190t","article-title":"Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor","volume":"2","author":"Johnson","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127513_b0115","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2125.2011.04137.x","article-title":"Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects","volume":"73","author":"Li","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bmcl.2020.127513_b0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cts.12548","article-title":"Fatty Acid amide hydrolase inhibition by JNJ-42165279: a multiple-ascending dose and a positron emission tomography study in healthy volunteers","volume":"11","author":"Postnov","year":"2018","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.bmcl.2020.127513_b0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40268-016-0127-y","article-title":"Safety, tolerability and pharmacokinetics of FAAH Inhibitor V158866: a double-blind, randomised, placebo-controlled phase I study in healthy volunteers","volume":"16","author":"Pawsey","year":"2016","journal-title":"Drugs R D"},{"key":"10.1016\/j.bmcl.2020.127513_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-20895-z","article-title":"The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents","volume":"8","author":"Griebel","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2020.127513_b0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/jnsbm.JNSBM_181_17","article-title":"French Phase I clinical trial disaster: issues, learning points, and potential safety measures","volume":"9","author":"Gupta","year":"2018","journal-title":"J Nat Sc Biol Med"},{"key":"10.1016\/j.bmcl.2020.127513_b0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature.2016.19189","article-title":"Scientists in the dark after fatal French clinical trial","volume":"529","author":"Ni","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2020.127513_b0145","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","article-title":"Positron emission tomography provides molecular imaging of biological processes","volume":"97","author":"Phelps","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2020.127513_b0150","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/cr0782426","article-title":"Molecular imaging with PET","volume":"108","author":"Ametamey","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2020.127513_b0155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd2290","article-title":"Molecular imaging in drug development","volume":"7","author":"Willmann","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2020.127513_b0160","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1021\/jacs.9b12116","article-title":"2H-azirine-based reagents for chemoselective bioconjugation at carboxyl residues inside live cells","volume":"142","author":"Ma","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2020.127513_b0165","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.addr.2010.09.011","article-title":"Approaches using molecular imaging technology \u2013 use of PET in clinical microdose studies","volume":"63","author":"Wagner","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2020.127513_b0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nucmedbio.2010.08.001","article-title":"[11C]CURB: evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography","volume":"38","author":"Wilson","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmcl.2020.127513_b0175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.nucmedbio.2010.03.009","article-title":"PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogue","volume":"37","author":"Wyffels","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmcl.2020.127513_b0180","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1021\/mp500316h","article-title":"PET imaging of fatty acid amide hydrolase with [18F]DOPP in nonhuman primates","volume":"11","author":"Rotstein","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2020.127513_b0185","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1016\/j.bmc.2013.04.077","article-title":"Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase","volume":"21","author":"Sadovski","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2020.127513_b0190","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.nucmedbio.2013.04.008","article-title":"Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase","volume":"40","author":"Hicks","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmcl.2020.127513_b0195","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.nucmedbio.2012.03.011","article-title":"The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH)","volume":"39","author":"Skaddan","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmcl.2020.127513_b0200","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","article-title":"PET radiotracers: crossing the blood-brain barrier and surviving metabolism","volume":"30","author":"Pike","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmcl.2020.127513_b0205","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cerebral Blood Flow Metabol"},{"key":"10.1016\/j.bmcl.2020.127513_b0210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biopsych.2016.04.012","article-title":"Fatty acid amide hydrolase binding in brain of cannabis users: imaging with the novel radiotracer [11C]CURB","volume":"80","author":"Boileau","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bmcl.2020.127513_b0215","article-title":"Fatty acid amide hydrolase is lower in young cannabis users","author":"Jacobson","year":"2020","journal-title":"Addict Biol"},{"key":"10.1016\/j.bmcl.2020.127513_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2020.03.003","article-title":"Imaging brain fatty acid amide hydrolase in untreated patients with psychosis","author":"Watts","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bmcl.2020.127513_b0225","first-page":"1","article-title":"Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C]CURB positron emission tomography study","author":"Kolla","year":"2020","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.bmcl.2020.127513_b0230","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/ml4000996","article-title":"Discovery of MK-3168: a PET tracer for imaging brain fatty acid amide hydrolase","volume":"4","author":"Liu","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127513_b0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acschemneuro.5b00248","article-title":"Synthesis and preliminary PET imaging studies of a FAAH radiotracer ([11C]MPPO) based on alpha-ketoheterocyclic scaffold","volume":"7","author":"Wang","year":"2016","journal-title":"ACS Chem Neurosci"},{"issue":"S1","key":"10.1016\/j.bmcl.2020.127513_b0240","first-page":"397","article-title":"Translational studies with [11C]MK\u00ad-3168, a PET tracer for fatty acid amide hydrolase (FAAH)","volume":"53","author":"Joshi","year":"2012","journal-title":"J Nucl Med"},{"issue":"S3","key":"10.1016\/j.bmcl.2020.127513_b0245","first-page":"362","article-title":"Kinetic modeling of fatty acid amide hydrolase (FAAH) enzyme occupancy after JNJ\u00ad42165279 inhibition based on 11C\u00ad-MK\u00ad3168 PET imaging of human brain","volume":"56","author":"Postnov","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2020.127513_b0250","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1021\/jm061414r","article-title":"Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase","volume":"50","author":"Hardouin","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127513_b0255","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1021\/ja902694n","article-title":"Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by alpha-ketoheterocycle inhibitors revealed from cocrystal structures","volume":"131","author":"Mileni","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2020.127513_b0260","unstructured":"Apodaca R, Breitenbucher JG, Chambers AL, et al. Oxazolyl piperidine modulators of fatty acid amide hydrolase. US patent application. 2007: WO2007\/140005A140002."},{"key":"10.1016\/j.bmcl.2020.127513_b0265","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.bmcl.2008.01.091","article-title":"Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH)","volume":"18","author":"Timmons","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127513_b0270","first-page":"23","article-title":"The diverse pharmacological importance of indole derivatives: a review","volume":"2","author":"Lalit","year":"2012","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.bmcl.2020.127513_b0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejmech.2018.02.065","article-title":"Indole in the target-based design of anticancer agents: a versatile scaffold with diverse mechanisms","volume":"150","author":"Dadashpour","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127513_b0280","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/jm400312y","article-title":"Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand","volume":"56","author":"Zhang","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127513_b0285","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/anie.201805501","article-title":"Chemistry for positron emission tomography: recent advances in 11C-, 18F-, 13N-, and 15O-labeling reactions","volume":"58","author":"Deng","year":"2019","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmcl.2020.127513_b0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0969-8043(00)00269-4","article-title":"An admonition when measuring the lipophilicity of radiotracers using counting techniques","volume":"54","author":"Wilson","year":"2001","journal-title":"Appl Radiat Isot"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20306247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20306247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:36:23Z","timestamp":1760772983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20306247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":58,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0960894X20306247"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127513","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and preliminary evaluation of a novel positron emission tomography (PET) ligand for imaging fatty acid amide hydrolase (FAAH)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127513"}}